Boehringer Ingelheim Animal Health USA Inc.

Ventipulmin clenbuterol CLENBUTEROL HYDROCHLORIDE CLENBUTEROL

Approved by FDA under NADA # 140-973 For oral use in horses only

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Federal law prohibits the extralabel use of this drug in food animals.

Clenbuterol HCl 72.5 mcg

Clenbuterol (4-amino-alpha-[(tert-butylamino) methyl]-3, 5-dichlorobenzyl alcohol hydrochloride) is a beta-2-adrenergic agonist which provides bronchodilating properties as well as other effects, with minimum effect on the cardiovascular system. It is provided as a colorless, palatable syrup. VENTIPULMIN Syrup (clenbuterol hydrochloride) is antagonized by beta-adrenergic blocking agents.

VENTIPULMIN Syrup (clenbuterol hydrochloride) is indicated for the management of horses affected with airway obstruction, such as occurs in chronic obstructive pulmonary disease (COPD).

VENTIPULMIN Syrup antagonizes the effects of prostaglandin F2 α and oxytocin. VENTIPULMIN Syrup should not be used in pregnant mares near term. Because tachycardia may occur, VENTIPULMIN Syrup should not be used in horses suspected of having cardiovascular impairment.

The effect on reproduction in breeding stallions and brood mares has not been determined. Treatment starting with dosages higher than the initial dose is not recommended.

Not for use in humans. Do not use in horses intended for human consumption. Keep out of reach of children. In case of accidental ingestion, contact a physician immediately. Ingestion of VENTIPULMIN Syrup may cause undesirable reactions. Clenbuterol, like other beta adrenergic agonists, can produce significant cardiovascular effects in some people as evidenced by elevated pulse rate, blood pressure changes and/or ECG changes.

Administer orally twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body weight (0.8 mcg/kg) twice daily.

Initial dosage: administer 0.5 mL/100 lbs (0.8 mcg/kg) for 3 days (6 treatments); If no improvement, administer 1.0 mL/100 lbs (1.6 mcg/kg) for 3 days (6 treatments); If no improvement, administer 1.5 mL/100 lbs (2.4 mcg/kg) for 3 days (6 treatments); If no improvement, administer 2.0 mL/100 lbs (3.2 mcg/kg) for 3 days (6 treatments); If no improvement, horse is non-responsive to clenbuterol and treatment should be discontinued. Recommended duration of treatment at effective dose is 30 days. At the end of this 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, the 30-day treatment regimen may be repeated. If repeating treatment, the step-wise dosage schedule should be repeated.

Remove safety cap and seal; replace with enclosed plastic dispensing cap. Remove cover from dispensing tip and connect syringe (without needle). Draw out appropriate volume of VENTIPULMIN Syrup. Administer orally to the horse. Replace cover on dispensing tip to prevent leakage.

Lbs. Body Weight	mL/treatment at 0.5 mL/100# (0.8 mcg/kg)	mL/treatment at 1.0 mL/100# (1.6 mcg/kg)	mL/treatment at 1.5 mL/100# (2.4 mcg/kg)	mL/treatment at 2.0 mL/100# (3.2 mcg/kg)
500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800	2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0	5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0	7.5 9.0 10.5 12.0 13.5 15.0 16.5 18.0 19.5 21.0 22.5 24.0 25.5 27.0	10.0 12.0 14.0 16.0 18.0 20.0 22.0 24.0 26.0 28.0 30.0 32.0 34.0 36.0

Administer two treatments per day.

The safety cap should be placed on the bottle when not in use.

Mild sweating, muscle tremor, restlessness, urticaria and tachycardia may be observed in some horses during the first few days of treatment. May cause elevated creatine kinase (CK) serum levels. Ataxia was observed in 3 out of 239 horses (1.3%) in clinical studies. To report suspected adverse events, for technical assistance, or to obtain a copy of the Safety Data Sheet (SDS), contact Boehringer Ingelheim Animal Health USA Inc. at 1-888-637-4251. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at www.fda.gov/reportanimalae.

VENTIPULMIN Syrup is available in 100 mL and 330 mL plastic bottles containing 72.5 mcg clenbuterol HCl per mL. NDC 0010-3017-02 – 100 mL, NDC 0010-3017-03 – 330 mL

Store at or below 25°C (77°F). Avoid freezing.

VENTIPULMIN is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Marketed by: Boehringer Ingelheim Animal Health USA Inc. Duluth, GA 30096

NDC 0010-3017-03 Ventipulmin® Syrup Clenbuterol HCl 72.5 mcg/mL Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Caution: Federal law prohibits the extralabel use of this drug in food animals. For oral use in horses only Approved by FDA under NADA # 140-973 Picture of the 330mL container label

NDC 0010-3017-03 Ventipulmin® Syrup Clenbuterol HCl 72.5 mcg/mL Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Caution: Federal law prohibits the extralabel use of this drug in food animals. For oral use in horses only Approved by FDA under NADA # 140-973 Picture of the front and side of the 330 mL display carton.

Picture of the front and side of the 330 mL display carton.